title: [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family].
abstract: In this report we describe different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets (ADHR) in 4 members of the same family as well as the treatment used in these patients and their response to it. Patient No 1: a 60 year old female who consulted for bone pain: Bone densitometry showed osteoporosis. Laboratory assays showed hypophosphatemia with low renal phosphate threshold, high total alkaline phosphatase, normal intact PTH and normal serum calcium. With neutral phosphate and calcitriol, the biochemical parameters normalized and bone densitometry improved significantly in less than a year. Patient No 2 her grand daughter consulted at 1 year and 8 months of age for growth retardation (height at percentile 3) and genu varum. Laboratory assays showed low serum phosphate and high total alkaline phosphatase; thickening and irregular epiphyseal borders of the wrists were observed radiologically. She began treatment with calcitriol and phosphorus with normalization of laboratory parameters and increase in growth (height increasing to percentile 50 after 20 months of therapy). Patient No 3: mother of patient No 2, she had no clinical manifestations and normal densitometry but presented low serum phosphate (1.9 mg/dl) that normalized with neutral phosphate therapy. Patient No 4: he was the youngest son of Patient No 1, who had had hypophosphatemic rickets, by age 5; his serum phosphate normalized without treatment At age 29, he presented normal serum phosphate and bone densitometry. Genomic DNA analysis performed in patient No 3, showed missense mutation with substitution of arginine at position 179 for glutamine. The family was catalogued as having autosomal dominant hypophosphatemic rickets/osteomalacia.
authors.affiliation: Instituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina. negri@casasco.com.ar
authors.forename: Armando Luis
authors.initials: AL
authors.lastname: Negri
authors.forename: Teresa
authors.initials: T
authors.lastname: Negrotti
authors.forename: Guillermo
authors.initials: G
authors.lastname: Alonso
authors.forename: Titania
authors.initials: T
authors.lastname: Pasqualini
mesh_terms: D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D002648:Child; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000235:genetics*; D006801:Humans; D007015:Hypophosphatemia, Familial / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D007223:Infant; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010018:Osteomalacia / Q000150:complications / Q000175:diagnosis / Q000235:genetics; D010375:Pedigree; D010710:Phosphates / Q000627:therapeutic use; D012279:Rickets / Q000150:complications / Q000175:diagnosis / Q000235:genetics*
chemical_list: C000717427:FGF23 protein, human; D010710:Phosphates; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D000469:Alkaline Phosphatase